MMCM
MDLN

Murphy & Mullick Capital Management’s Medline Inc MDLN Stock Holding History

Murphy & Mullick Capital Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7K Buy
+375
New +$16.6K 0.01% 412

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Murphy & Mullick Capital Management's MDLN Position: Q1 2026 in Review

Murphy & Mullick Capital Management opened a new position in Medline Inc (MDLN) in Q1 2026: 375 shares worth $16.7K. The stake represents 0.01% of the portfolio and ranks #412 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Murphy & Mullick Capital Management held 375 shares of Medline Inc worth $16.7K as of Q1 2026.
  • Medline Inc was a new Murphy & Mullick Capital Management position in Q1 2026.
  • Medline Inc made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #412 holding.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.